Detalles de la búsqueda
1.
Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.
Ann Hematol
; 96(9): 1463-1470, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28725989
2.
Single versus tandem high-dose melphalan followed by autologous blood stem cell transplantation in multiple myeloma: long-term results from the phase III GMMG-HD2 trial.
Br J Haematol
; 173(5): 731-41, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26990892
3.
Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years.
J Cancer Res Clin Oncol
; 148(5): 1171-1181, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34176014
4.
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2).
Genes Chromosomes Cancer
; 48(2): 179-83, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19006078
5.
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median followup of 14.4 years.
J Cancer Res Clin Oncol
; 149(2): 929-931, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083312
6.
Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: Results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG).
Blood
; 108(13): 4003-8, 2006 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16946304
7.
The addition of rituximab to a combination of fludarabine, cyclophosphamide, mitoxantrone (FCM) significantly increases the response rate and prolongs survival as compared with FCM alone in patients with relapsed and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood
; 104(10): 3064-71, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15284112
Resultados
1 -
7
de 7
1
Próxima >
>>